Generally, higher expressions of GAS5 were usually accompanied by lower expressions of YAP and YTHDF3, while lower expressions of GAS5 were associated with elevated expressions of YAP and YTHDF3 in tumor tissues from CRC patients (Fig. 7b). The gene discussed is GAS5; the disease is neoplasm.